Patents by Inventor Assaf Alon

Assaf Alon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200000822
    Abstract: The present disclosure provides methods of treating cancer, sterol homeostasis diseases, and neurological diseases using compounds which modulate the activity of sigma receptors. In particular, the present disclosure provides method s of modulating the sigma 2 receptor for use in treating one or more diseases associated with that sigma receptor.
    Type: Application
    Filed: February 23, 2018
    Publication date: January 2, 2020
    Inventors: Andrew Curtis KRUSE, Assaf ALON, Hayden R. SCHMIDT, Stephen MARTIN, James SAHN, Michael WOOD
  • Publication number: 20170247468
    Abstract: A method of inhibiting or preventing laminin assembly in a basement membrane is disclosed. The method comprising contacting a tissue with an agent which inhibits QSOX1 activity or expression, thereby inhibiting or preventing laminin assembly in the basement membrane.
    Type: Application
    Filed: April 24, 2017
    Publication date: August 31, 2017
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Deborah FASS, Iris GROSSMAN, Tal ILANI, Assaf ALON
  • Patent number: 9631028
    Abstract: A method of inhibiting or preventing laminin assembly in a basement membrane is disclosed. The method comprising contacting a tissue with an agent which inhibits QSOX1 activity or expression, thereby inhibiting or preventing laminin assembly in the basement membrane.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: April 25, 2017
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Deborah Fass, Iris Grossman, Tal Ilani, Assaf Alon
  • Publication number: 20150110786
    Abstract: A method of inhibiting or preventing laminin assembly in a basement membrane is disclosed. The method comprising contacting a tissue with an agent which inhibits QSOX1 activity or expression, thereby inhibiting or preventing laminin assembly in the basement membrane.
    Type: Application
    Filed: March 7, 2013
    Publication date: April 23, 2015
    Inventors: Deborah Fass, Iris Grossman, Tal Ilani, Assaf Alon